Skip to content
Chemicals, Materials & Nutrition

Global Medical Food Growth Opportunities

Collaborative Efforts Between Drug Manufacturers and Medical Food Manufacturers to Boost Growth Opportunities for Medical Food

The US FDA defines medical food as “a food, which is formulated to be consumed or administered enterally under the supervision of a physician and which is intended for the specific dietary management of a disease or condition for which distinctive nutritional requirements, based on recognized scientific principles, are established by medical evaluation.“ Medical food is interpreted as 'food for special medical purposes (FSMPs)' in several countries, including Europe, India, China, and Australia and New Zealand. In Japan, medical food is interpreted as 'food for sick'. In Canada, medical food is governed by food for special dietary use (FSDU) and infant food regulations.

Globally, the regulatory landscape for medical food is not clearly defined, even in developed economies. As medical food is not intended to prevent or treat diseases, it is not subject to the same regulatory requirements as pharmaceutical drugs.

The above deliverable is the latest addition to Frost & Sullivan’s Chemicals, Materials & Nutrition research and analyses, available through the Frost & Sullivan Growth Partnership Services, which help organizations identify a continuous flow of growth opportunities to succeed in an unpredictable future.

Download Preview

Sign up for a complimentary Growth Pipeline Dialog™

A Growth Pipeline Dialog is a structured open discussion with our growth experts providing unparalleled market intelligence, technology insights, and proven implementation best practices. This discussion will spark innovative thinking and help generate a pipeline of growth opportunities you can leverage to maximize your company’s future growth potential.

drive-growth-image-scaled-2